Stay updated on Immunotherapy for Anal Canal Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Anal Canal Cancer Clinical Trial page.

Latest updates to the Immunotherapy for Anal Canal Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2; removed the prior government funding status notice and Revision: v3.4.1, reflecting an administrative update to the site header.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a government funding notice about NIH operations and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedShow glossary is now displayed. Status area updated to show 'Results Submitted' and 'Last Update Submitted that Met QC Criteria' along with a new revision tag (v3.4.0), replacing the previous version.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page shows a minor revision update from Revision: v3.3.3 to Revision: v3.3.4; no substantive changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section updated to include Ontario and to remove the previous Ontario Locations entry, with a broader reorganization of location listings. The HHS Vulnerability Disclosure footer was removed and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedThe PubMed publication note was updated to clarify automatic filling and that articles may or may not be about the study. The page revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy for Anal Canal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Anal Canal Cancer Clinical Trial page.